Digestive Diseases

Pathophysiology of IBD and Age of Onset

The Intestinal Epithelial Barrier: Does It Become Impaired with Age?

Meier J. · Sturm A.

Author affiliations

Medizinische Klinik m.S. Hepatologie, Gastroenterologie, Endokrinologie und Stoffwechsel, Charité-Universitätsmedizin Berlin, Campus Virchow-Klinikum, Berlin, Germany

Related Articles for ""

Dig Dis 2009;27:240–245

Log in to MyKarger to check if you already have access to this content.


Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!


If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.

Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select
* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Pathophysiology of IBD and Age of Onset

Published online: September 24, 2009
Issue release date: September 2009

Number of Print Pages: 6
Number of Figures: 0
Number of Tables: 0

ISSN: 0257-2753 (Print)
eISSN: 1421-9875 (Online)

For additional information: https://www.karger.com/DDI

Abstract

The proportion of the population aged over 65 is increasing rapidly and malnutrition is a more common problem in elderly patients. The intestinal epithelium covers the surface of the digestive tract and consists of epithelial cells that constitute an efficient physical barrier between the dietary and enteric flora pathogens found in the intestinal lumen and the individuum, while at the same time allowing an exchange between nutrients and the systemic circulation. There is only a very limited amount of information available on whether and how age, with concomitant inflammation, influences the epithelial barrier. Although there is evidence that age does not correlate with the area of the duodenal surface epithelium or the number of intraepithelial lymphocytes, absorption of certain nutrients, e.g. lipids, does seem to be impaired in the elderly. However, impaired blood flow, ischemic changes and the increased use of NSAIDs naturally contribute to an impaired epithelial barrier in elderly patients.

© 2009 S. Karger AG, Basel




Related Articles:


References

  1. Madara JL, Nash S, Moore R, et al: Structure and function of the intestinal epithelial barrier in health and disease. Monogr Pathol 1990;31:306–324.
    External Resources
  2. Scheiman JM: NSAIDs, gastrointestinal injury, and cytoprotection. Gastroenterol Clin North Am 1996;25:279–298.
  3. Schmitz MG, Renooij W: Phospholipids from rat, human, and canine gastric mucosa: composition and metabolism of molecular classes of phosphatidylcholine. Gastroenterology 1990;99:1292–1296.
  4. Maury J, Nicoletti C, Guzzo-Chambraud L, et al: The filamentous brush border glycocalyx, a mucin-like marker of enterocyte hyper-polarization. Eur J Biochem 1995;228:323–331.
  5. Slomiany A, Grabska M, Slomiany BL: Essential components of antimicrobial gastrointestinal epithelial barrier: specific interaction of mucin with an integral apical membrane protein of gastric mucosa. Mol Med 2001;7:1–10.
  6. Frey A, Giannasca KT, Weltzin R, et al: Role of the glycocalyx in regulating access of microparticles to apical plasma membranes of intestinal epithelial cells: implications for microbial attachment and oral vaccine targeting. J Exp Med 1996;184:1045–1059.
  7. Kraehenbuhl JP, Pringault E, Neutra MR: Review article: Intestinal epithelia and barrier functions. Aliment Pharmacol Ther 1997;11(suppl 3):3–8; discussion 8–9.
    External Resources
  8. Potten CS, Kellett M, Rew DA, et al: Proliferation in human gastrointestinal epithelium using bromodeoxyuridine in vivo: data for different sites, proximity to a tumour, and polyposis coli. Gut 1992;33:524–529.
  9. Cheng H, Leblond CP: Origin, differentiation and renewal of the four main epithelial cell types in the mouse small intestine. III. Entero-endocrine cells. Am J Anat 1974;141:503–519.
  10. Schmidt GH, Wilkinson MM, Ponder BA: Cell migration pathway in the intestinal epithelium: an in situ marker system using mouse aggregation chimeras. Cell 1985;40:425–429.
  11. McCormack SA, Viar MJ, Johnson LR: Migration of IEC-6 cells: a model for mucosal healing. Am J Physiol 1992;263:G426–G435.
  12. Nusrat A, Delp C, Madara JL: Intestinal epithelial restitution. Characterization of a cell culture model and mapping of cytoskeletal elements in migrating cells. J Clin Invest 1992;89:1501–1511.
  13. Moore R, Carlson S, Madara JL: Rapid barrier restitution in an in vitro model of intestinal epithelial injury. Lab Invest 1989;60:237–244.
  14. Feil W, Wenzl E, Vattay P, et al: Repair of rabbit duodenal mucosa after acid injury in vivo and in vitro. Gastroenterology 1987;92:1973–1986.
  15. Taupin D, Podolsky DK: Trefoil factors: Initiators of mucosal healing. Nat Rev Mol Cell Biol 2003;4:721–732.
  16. Fiocchi C: Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 1998;115:182–205.
  17. Dignass AU, Sturm A, Podolsky D: Epithelial injury and restitution; in Domschke W, Stoll T, Brasitius TA, Kagnoff MF (eds): Intestinal Mucosa and Its Diseases. Dordrecht, Kluwer Academic Publisher, 1999, pp 293–299.
  18. Okamoto R, Watanabe M: Cellular and molecular mechanisms of the epithelial repair in IBD. Dig Dis Sci 2005;50(suppl 1):S34–S38.
  19. Okamoto R, Watanabe M: Molecular and clinical basis for the regeneration of human gastrointestinal epithelia. J Gastroenterol 2004;39:1–6.
  20. Dignass AU, Sturm A: Peptide growth factors in the intestine. Eur J Gastroenterol Hepatol 2001;13:763–770.
  21. Lipski PS, Bennett MK, Kelly PJ, et al: Ageing and duodenal morphometry. J Clin Pathol 1992;45:450–452.
  22. Keelan M, Walker K, Thomson AB: Intestinal morphology, marker enzymes and lipid content of brush border membranes from rabbit jejunum and ileum: effect of aging. Mech Ageing Dev 1985;31:49–68.
  23. Ma TY, Hollander D, Dadufalza V, et al: Effect of aging and caloric restriction on intestinal permeability. Exp Gerontol 1992;27:321–333.
  24. Beaumont DM, Cobden I, Sheldon WL, et al: Passive and active carbohydrate absorption by the ageing gut. Age Ageing 1987;16:294–300.
  25. Saweirs WM, Andrews DJ, Low-Beer TS: The double sugar test of intestinal permeability in the elderly. Age Ageing 1985;14:312–315.
  26. Saltzman JR, Kowdley KV, Perrone G, et al: Changes in small-intestine permeability with aging. J Am Geriatr Soc 1995;43:160–164.
  27. Holt PR, Balint JA: Effects of aging on intestinal lipid absorption. Am J Physiol 1993;264:G1–G6.
  28. Arora S, Kassarjian Z, Krasinski SD, et al: Effect of age on tests of intestinal and hepatic function in healthy humans. Gastroenterology 1989;96:1560–1565.
  29. Salemans JM, Nagengast FM, Tangerman A, et al: Effect of ageing on postprandial conjugated and unconjugated serum bile acid levels in healthy subjects. Eur J Clin Invest 1993;23:192–198.
  30. Wisen O, Hellstrom PM: Gastrointestinal motility in obesity. J Intern Med 1995;237:411–418.
  31. Woudstra TD, Drozdowski LA, Wild GE, et al: An isocaloric PUFA diet enhances lipid uptake and weight gain in aging rats. Lipids 2004;39:343–354.
  32. Doubek WG, Armbrecht HJ: Changes in intestinal glucose transport over the lifespan of the rat. Mech Ageing Dev 1987;39:91–102.
  33. Freeman HJ, Quamme GA: Age-related changes in sodium-dependent glucose transport in rat small intestine. Am J Physiol 1986;251:G208–G217.
  34. Hosoda S: The gastrointestinal tract and nutrition in the aging process: an overview. Nutr Rev 1992;50:372–373.
  35. Lindi C, Marciani P, Faelli A, et al: Intestinal sugar transport during ageing. Biochim Biophys Acta 1985;816:411–414.
  36. Ferraris RP, Vinnakota RR: Regulation of intestinal nutrient transport is impaired in aged mice. J Nutr 1993;123:502–511.
  37. Drozdowski L, Woudstra T, Wild G, et al: The age-associated decline in the intestinal uptake of glucose is not accompanied by changes in the mRNA or protein abundance of SGLT1. Mech Ageing Dev 2003;124:1035–1045.
  38. Thompson JS, Crouse DA, Mann SL, et al: Intestinal glucose uptake is increased in aged mice. Mech Ageing Dev 1988;46:135–143.
  39. Chen TS, Currier GJ, Wabner CL: Intestinal transport during the life span of the mouse. J Gerontol 1990;45:B129–B133.
  40. Gomez CR, Boehmer ED, Kovacs EJ: The aging innate immune system. Curr Opin Immunol 2005;17:457–462.
  41. Weng NP: Aging of the immune system: how much can the adaptive immune system adapt? Immunity 2006;24:495–499.
  42. Katz JM, Plowden J, Renshaw-Hoelscher M, et al: Immunity to influenza: the challenges of protecting an aging population. Immunol Res 2004;29:113–124.
  43. Boren E, Gershwin ME: Inflamm-aging: autoimmunity, and the immune-risk phenotype. Autoimmun Rev 2004;3:401–406.
  44. Effros RB: Genetic alterations in the ageing immune system: impact on infection and cancer. Mech Ageing Dev 2003;124:71–77.
  45. Prelog M: Aging of the immune system: a risk factor for autoimmunity? Autoimmun Rev 2006;5:136–139.
  46. Min H, Montecino-Rodriguez E, Dorshkind K: Reduction in the developmental potential of intrathymic T cell progenitors with age. J Immunol 2004;173:245–250.
  47. Garcia GG, Miller RA: Differential tyrosine phosphorylation of zeta chain dimers in mouse CD4 T lymphocytes: effect of age. Cell Immunol 1997;175:51–57.
  48. Song H, Price PW, Cerny J: Age-related changes in antibody repertoire: contribution from T cells. Immunol Rev 1997;160:55–62.
  49. Han S, Yang K, Ozen Z, et al: Enhanced differentiation of splenic plasma cells but diminished long-lived high-affinity bone marrow plasma cells in aged mice. J Immunol 2003;170:1267–1273.
  50. Arranz E, O’Mahony S, Barton JR, et al: Immunosenescence and mucosal immunity: significant effects of old age on secretory IgA concentrations and intraepithelial lymphocyte counts. Gut 1992;33:882–886.
  51. Ebersole JL, Smith DJ, Taubman MA: Secretory immune responses in ageing rats. I. Immunoglobulin levels. Immunology 1985;56:345–350.
  52. Schmucker DL, Thoreux K, Owen RL: Aging impairs intestinal immunity. Mech Ageing Dev 2001;122:1397–1411.
  53. Schmucker DL, Owen RL, Outenreath R, et al: Basis for the age-related decline in intestinal mucosal immunity. Clin Dev Immunol 2003;10:167–172.
  54. Fujihashi K, Koga T, McGhee JR: Mucosal vaccination and immune responses in the elderly. Vaccine 2000;18:1675–1680.
  55. Gomez CR, Nomellini V, Faunce DE, et al: Innate immunity and aging. Exp Gerontol 2008;43:718–728.
  56. Fulop T, Larbi A, Douziech N, et al: Signal transduction and functional changes in neutrophils with aging. Aging Cell 2004;3:217–226.
  57. Tortorella C, Simone O, Piazzolla G, et al: Age-related impairment of GM-CSF-induced signalling in neutrophils: role of SHP-1 and SOCS proteins. Ageing Res Rev 2007;6:81–93.
  58. Ishimoto Y, Tomiyama-Miyaji C, Watanabe H, et al: Age-dependent variation in the proportion and number of intestinal lymphocyte subsets, especially natural killer T cells, double-positive CD4+ CD8+ cells and B220+ T cells, in mice. Immunology 2004;113:371–377.
  59. Mariani E, Pulsatelli L, Meneghetti A, et al: Different IL-8 production by T and NK lymphocytes in elderly subjects. Mech Ageing Dev 2001;122:1383–1395.
  60. Mocchegiani E, Malavolta M: NK and NKT cell functions in immunosenescence. Aging Cell 2004;3:177–184.
  61. Peralbo E, Alonso C, Solana R: Invariant NKT and NKT-like lymphocytes: two different T cell subsets that are differentially affected by ageing. Exp Gerontol 2007;42:703–708.
  62. Fietta A, Merlini C, De Bernardi PM, et al: Nonspecific immunity in aged healthy subjects and in patients with chronic bronchitis. Aging (Milano) 1993;5:357–361.
  63. Plackett TP, Boehmer ED, Faunce DE, et al: Aging and innate immune cells. J Leukoc Biol 2004;76:291–299.
  64. Corsini E, Di PR, Viviani B, et al: Increased carrageenan-induced acute lung inflammation in old rats. Immunology 2005;115:253–261.
  65. Plowden J, Renshaw-Hoelscher M, Gangappa S, et al: Impaired antigen-induced CD8+ T cell clonal expansion in aging is due to defects in antigen presenting cell function. Cell Immunol 2004;229:86–92.
  66. van Duin D, Shaw AC: Toll-like receptors in older adults. J Am Geriatr Soc 2007;55:1438–1444.
  67. van Duin D, Mohanty S, Thomas V, et al: Age-associated defect in human TLR-1/2 function. J Immunol 2007;178:970–975.
  68. Piront P, Louis E, Latour P, et al: Epidemiology of inflammatory bowel diseases in the elderly in the province of Liege. Gastroenterol Clin Biol 2002;26:157–161.
  69. Redzic ZB, Preston JE, Duncan JA, et al: The choroid plexus-cerebrospinal fluid system: from development to aging. Curr Top Dev Biol 2005;71:1–52.
  70. Kelly J, Ali KA, Yin J, et al: Senescence regulates macrophage activation and angiogenic fate at sites of tissue injury in mice. J Clin Invest 2007;117:3421–3426.
  71. Woudstra T, Thomson AB: Nutrient absorption and intestinal adaptation with ageing. Best Pract Res Clin Gastroenterol 2002;16:1–15.

Article / Publication Details

First-Page Preview
Abstract of Pathophysiology of IBD and Age of Onset

Published online: September 24, 2009
Issue release date: September 2009

Number of Print Pages: 6
Number of Figures: 0
Number of Tables: 0

ISSN: 0257-2753 (Print)
eISSN: 1421-9875 (Online)

For additional information: https://www.karger.com/DDI


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
TOP